The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Case Report
Central Retinal Vein Occlusion in Sickle Cell Disease
Abstract
Central retinal vein occlusion has not been reported previously in patients with sickle cell anemia. We describe the case of a 31-year-old man with sickle cell anemia who developed this complication. The search for risk factors for central retinal vein occlusion in this young patient revealed protein S deficiency and a history of iron deficiency. He was treated with anticoagulation therapy, and his vision improved gradually.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Bayazit AK, Kilinc Y. Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state. Pediatr Int 2001; 43: 592–596.
2. el-Hazmi MA, Warsy AS, Bahakim H. Blood proteins C and S in sickle cell disease. Acta Haematol 1993; 90: 114–119.
3. Greiner K, Hafner G, Dick B, et al. Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 1999; 128: 69–74.
4. Bertram B, Remky A, Arend O, et al. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 1995; 4: 332–335.
5. Kirkham TH, Wrigley PF, Holt JM. Central retinal vein occlusion complicating iron deficiency anaemia. Br J Ophthalmol 1971; 55: 777–780.
6. Tashiro T, Takahashi H, Masuda H, et al. Complication of central retinal vein occlusion in iron deficiency anemia [in Japanese]. Meikai Daigaku Shigaku Zasshi 1990; 19: 437–442.
7. Kacer B, Hattenbach LO, Horle S, et al. Central retinal vein occlusion and nonarteritic ischemic optic neuropathy in 2 patients with mild iron deficiency anemia. Ophthalmologica 2001; 215: 128–131.
8. Castro O, Poillon WN, Finke H, et al. Improvement of sickle cell anemia by iron-limited erythropoiesis. Am J Hematol 1994; 47: 74–81.
9. Appiah AP, Trempe CL. Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophthalmol 1989; 21: 153–157.
10. Dodson PM, Kubicki AJ, Taylor KG, et al. Medical conditions underlying recurrence of retinal vein occlusion. Br J Ophthalmol 1985; 69: 493–496.
11. Gupta A, Agarwal A, Bansal RK, et al. Ischaemic central retinal vein occlusion in the young. Eye 1993; 7: 138–142.
12. Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996; 80: 200–202.
13. Walters RF, Spalton DJ. Central retinal vein occlusion in people aged 40 years or less: A review of 17 patients. Br J Ophthalmol 1990; 74: 30–35.
14. Williamson TH, Rumley A, Lowe GD. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: A population controlled study. Br J Ophthalmol 1996; 80: 203–208.
15. Gowers WR. Manual and Atlas of Medical Ophthalmoscopy. London, Churchill, 1904, ed 4, p. 227.
16. Pears MA, Pickering GW. Changes in the fundus oculi after haemorrhage. Q J Med 29: 153, 1960.
17. Holt JM, Gordon-Smith EC. Retinal abnormalities in diseases of the blood. Br J Ophthalmol 1969; 53: 145–160.
18. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep 1998; 47: (RR-3): 1–29.
